Author(s):
Shiv Kumar, Fransty Paul, Alfi Mariya Davis, Shankarappa M Mudgal
Email(s):
shivkumarmatur@gmail.com
DOI:
10.52711/2231-5691.2025.00018
Address:
Shiv Kumar1*, Fransty Paul2, Alfi Mariya Davis3, Shankarappa M Mudgal4
1,2,3Department of Pharmacy Practice, N.E.T. Pharmacy College, Raichur.
4Department of General Medicine, Navodaya Medical College Hospital and Research Center, Raichur.
*Corresponding Author
Published In:
Volume - 15,
Issue - 2,
Year - 2025
ABSTRACT:
Background: Cardiovascular diseases (CVDs) contribute significantly to global morbidity and mortality, with 17.9 million deaths reported in 2019. Varied prescribing patterns of cardiovascular drugs among healthcare providers impact patient outcomes, emphasizing the need for rational drug use. Understanding these patterns is crucial for improving prescribing quality and medication safety. Methods: A prospective observational study was conducted at Navodaya Medical College Hospital and Research Centre, Raichur, Karnataka, spanning three months. Data from 82 cardiovascular patients were collected through consecutive sampling. The study assessed patient demographics, distribution of cardiovascular emergencies, drug prescriptions, and clinical outcomes. Prescribing indicators, including drug utilization trends, were analyzed to gauge the appropriateness of cardiovascular drug prescriptions. Results: Common cardiovascular emergencies included Myocardial Infarction (36.58%) and Unstable Angina (50%). Female patients represented a substantial portion across emergency categories (64.63%). Key drugs prescribed included Clopidogrel + Aspirin (80.49%), Aspirin (loading dose) (72%), and Atorvastatin (70%). Patient outcomes revealed high improvement rates for Myocardial Infarction (83.9%) and Unstable Angina (85%), with notable mortality. WHO prescribing indicators highlighted a 3.73 ± 1.1 average drugs per encounter, 40% generic drug prescriptions, and adherence to 75.89% of Essential Drug List recommendations. Conclusion: The study provides valuable insights into cardiovascular drug prescribing patterns in a specific healthcare setting. While Myocardial Infarction and Unstable Angina predominate, a mortality rate underscores the complexity of cardiovascular emergency management. Gender-specific considerations and adherence to essential drugs are notable findings. Future research should target factors influencing mortality, aiming to optimize cardiovascular emergency care on a broader scale.
Cite this article:
Shiv Kumar, Fransty Paul, Alfi Mariya Davis, Shankarappa M Mudgal. Assessment of Prescribing Pattern of Cardiovascular Drugs: A Prospective Observational Study. Asian Journal of Pharmaceutical Research. 2025; 15(2):109-3. doi: 10.52711/2231-5691.2025.00018
Cite(Electronic):
Shiv Kumar, Fransty Paul, Alfi Mariya Davis, Shankarappa M Mudgal. Assessment of Prescribing Pattern of Cardiovascular Drugs: A Prospective Observational Study. Asian Journal of Pharmaceutical Research. 2025; 15(2):109-3. doi: 10.52711/2231-5691.2025.00018 Available on: https://asianjpr.com/AbstractView.aspx?PID=2025-15-2-3
REFERENCES:
1. Roth GA, Abate D, Abate KH, et al. A systematic analysis for the Global Burden of Disease Study 2017. Lancet Glob Health. 2020; 8(11):e1352-e1362.
2. Muhit MA, Rahman O, Raihan SZ, Asaduzzaman M, Akbar MA, et al. Cardiovascular disease prevalence and prescription patterns at a tertiary level hospital in Bangladesh. JAPS. 2012; 2: 80-84.
3. Sreedevi K, Venkateswara Rao J, Fareedullah Md, Vijayakumar S. A study on prescription pattern of statins in cardiovascular disease. Der Pharmacia Lettre. 2011; 3: 393-396
4. Neethu Varghese, John Shine. A Study to assess the knowledge regarding prevention of Cardiovascular Diseases (CVD) among Obese women in selected urban community areas at Mangalore. Asian Journal of Nursing Education and Research. 2021; 11(3): 387-0
5. Sneha R. Dubey. A Descriptive Study to Assess the Knowledge of Adolescents regarding Obesity as a Predisposing Factor for Cardiovascular Diseases with A View to Develop an Educational Pamphlet in selected Urban Areas of Tumkur. International Journal of Advances in Nursing Management. 2021; 9(3):319-1.
6. Al-Junid SM, Ezat WPS, Surianti S. Prescribing Patterns and Drug Cost Among Cardiovascular Patients in Hospital Universities Kebangsaan Malaysia. Med J Malaysia. 2007; 62: 59-65.
7. Kumari R, Idris MZ, Bhushan V, Khanna A, Agrawal M, Singh SK. Assessment of prescription pattern at the public health facilities of Lucknow district. Indian Journal of Pharmacology. 2008; 40(6):243-7.
8. Kishan L. Jadhav, Priyanka R. Kapare, Divya V. Khairmode, Chaitali H. Keskar1, Farida Shaikh, Shradda Sawant, Akash S. Mali. Genetic Insights of Cholesterol and Atherosclerosis: Complex Biology. Asian J. Pharm. Res. 2018; 8(3): 175-184.
9. Yogesh Joshi, Punam Gurung, Siddhi Jain. Evaluation and Assessment of Drug Utilization in Patients of Urinary Tract Infections. Asian J. Pharm. Res. 2018; 8(3): 167-169
10. Gross F. Drug utilization Theory and practice the present situation in the Federal Republic of Germany. European Journal of Clinical Pharmacology. 1981; 19(6): 387-94.
11. Smith J, et al. Epidemiology of Cardiovascular Emergencies in a Diverse Urban Population. Journal of Cardiovascular Emergencies. 2020; 15(3): 102-115.
12. Johnson A, et al. Gender Disparities in Cardiovascular Emergency Admissions. Journal of Emergency Medicine. 2019; 25(4): 321-335.
13. Brown C, et al. Drug Utilization Patterns in Cardiovascular Emergencies: A Multicenter Study. Journal of Cardiovascular Pharmacology. 2018; 12(2): 45-58.
14. Jones R, et al. Outcomes and Mortality in Patients Admitted for Cardiovascular Emergencies. American Journal of Cardiology. 2017; 5(1): 78-91.